Get my own profile
Public access
View all13 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Roderick HubbardUniversity of York and Vernalis (R&D) LtdVerified email at york.ac.uk
- Allan JordanVice President of Oncology Drug Discovery, Sygnature DiscoveryVerified email at thejordans.org.uk
- terance hartDirector of ResearchVerified email at geistlich.ch
- Xavier BarrilICREA Research Professor, University of BarcelonaVerified email at ub.edu
- Neil PressNovartisVerified email at novartis.com
- Brian DymockDirector of ChemistryVerified email at uniquest.com.au
- Paul WorkmanChief Executive & President, Institute of Cancer Research, LondonVerified email at icr.ac.uk
- Nicolas BaurinSanofiPasteurVerified email at sanofipasteur.com
- Javier LuqueUniversity of Barcelona - Institut of BiomedicineVerified email at ub.edu
- Peter SchmidtkeDiscngineVerified email at discngine.com
- Paul RaithbyProfessor of Inorganic Chemistry, University of BathVerified email at bath.ac.uk
- Andras KotschyServier Research Institute of Medicinal ChemistryVerified email at servier.com
- Georg LentzenManaging Director, b-value AGVerified email at b-value.de
- Annabella F. NewtonPhillips Ormonde FitzpatrickVerified email at pof.com.au
- Jonathan D. MooreHorizon DiscoveryVerified email at horizondiscovery.com
- John A HICKMANIndependent